{"nct_id":"NCT00487435","title":"An Open-label Extension Study With Flexible Dosing of Extended-release (ER) Tapentadol (CG5503) to Treat Patients With Moderate to Severe Chronic Pain","status":"COMPLETED","status_verified_date":"2014-04","start_date":"2007-06","start_date_type":null,"primary_completion_date":"2009-06","primary_completion_date_type":"ACTUAL","completion_date":"2009-06","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["JNJ"]}